Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review

August 2021 | 47 pages | ID: YBA50ACD5807EN
GlobalData

Abstracts

Ypsomed Holding AG (YPSN)

Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, therapy management, monitoring services, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG Key Recent Developments

May 26,2021: Ypsomed continues to invest in growth
Jan 04,2021: Ypsomed reaches agreement in legal dispute with Insulet
Jul 02,2020: Ypsomed’s Annual General Meeting approves all proposals and elects Gilbert Achermann as a new member of the Board of Directors
May 27,2020: Ypsomed grows strongly in pharma customer business and continues to invest in the market development of the insulin pump

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Ypsomed Holding AG - Key Facts
Ypsomed Holding AG - Key Employees
Ypsomed Holding AG - Key Employee Biographies
Ypsomed Holding AG - Major Products and Services
Ypsomed Holding AG - History
Ypsomed Holding AG - Company Statement
Ypsomed Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ypsomed Holding AG - Business Description
Business Segment: Others
Overview
Performance
Business Segment: Ypsomed Delivery Systems
Overview
Performance
Business Segment: Ypsomed Diabetes Care
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Switzerland
Performance
R&D Overview
Ypsomed Holding AG - Corporate Strategy
Ypsomed Holding AG - SWOT Analysis
SWOT Analysis - Overview
Ypsomed Holding AG - Strengths
Ypsomed Holding AG - Weaknesses
Ypsomed Holding AG - Opportunities
Ypsomed Holding AG - Threats
Ypsomed Holding AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ypsomed Holding AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ypsomed Holding AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ypsomed Holding AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 26, 2021: Ypsomed continues to invest in growth
Jan 04, 2021: Ypsomed reaches agreement in legal dispute with Insulet
Jul 02, 2020: Ypsomed’s Annual General Meeting approves all proposals and elects Gilbert Achermann as a new member of the Board of Directors
May 27, 2020: Ypsomed grows strongly in pharma customer business and continues to invest in the market development of the insulin pump

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Ypsomed Holding AG, Key Facts
Ypsomed Holding AG, Key Employees
Ypsomed Holding AG, Key Employee Biographies
Ypsomed Holding AG, Major Products and Services
Ypsomed Holding AG, History
Ypsomed Holding AG, Subsidiaries
Ypsomed Holding AG, Key Competitors
Ypsomed Holding AG, Ratios based on current share price
Ypsomed Holding AG, Annual Ratios
Ypsomed Holding AG, Annual Ratios (Cont...1)
Ypsomed Holding AG, Annual Ratios (Cont...2)
Ypsomed Holding AG, Interim Ratios
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ypsomed Holding AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Ypsomed Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Ypsomed Holding AG, Performance Chart (2017 - 2021)
Ypsomed Holding AG, Ratio Charts
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2015 to YTD 2021